Showing results (341-350 of 358) with videos related to
Sort By:
Pageof 36
Blood Cells|January 1, 1987
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesisK Welte, M A Bonilla, J L Gabrilove, et al.The Journal of Experimental Medicine|April 1, 1987
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primatesK Welte, M A Bonilla, A P Gillio, et al.Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigenS J Forman, J A Zaia, B R Clark, et al.Bone Marrow Transplantation|December 8, 2004
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)L Grigull, A Beilken, M Schrappe, et al.Clinical and Experimental Immunology|November 13, 2001
Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95J M Shaw, A Al-Shamkhani, L A Boxer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approachC Beger, L N Pierce, M Kruger, et al.Cancer|August 15, 1983
Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastomaK A Rickard, C M Detamore, T D Coates, et al.Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.Pageof 36